Table |
||||||
|
|
||||||
|
Early-onset NLRTI/no NLRTI (n = 68/3164) |
Late-onset NLRTI/no NLRTI (n = 449/3164) |
|||||
|
|
|
|||||
|
Multivariate analysis |
OR |
95% CI |
P |
OR |
95% CI |
P |
|
|
||||||
|
Stress ulcer prevention |
6.48 |
3.64–11.55 |
< 0.001 |
- |
- |
- |
|
Digestive failure |
3.26 |
1.33–7.98 |
0.009 |
- |
- |
- |
|
Tracheotomy |
2.69 |
1.22–5.91 |
0.014 |
- |
- |
- |
|
Renal failure |
2.17 |
1.14–4.13 |
0.018 |
- |
- |
- |
|
Corticotherapy |
1.81 |
1.06–3.09 |
0.028 |
1.64 |
1.20–2.25 |
0.002 |
|
Ranitidine |
- |
- |
- |
6.36 |
3.23–12.53 |
< 0.001 |
|
Omeprazole |
- |
- |
- |
3.77 |
1.34–10.58 |
0.012 |
|
Sucralfate |
- |
- |
- |
2.11 |
1.57–2.84 |
< 0.001 |
|
Number of antibiotics |
- |
- |
- |
1.45 |
1.23–1.69 |
< 0.001 |
|
Duration of MV |
- |
- |
- |
1.13 |
1.11–1.14 |
< 0.001 |
|
|
||||||
|
Nseir et al. Critical Care 2002 6(Suppl 1):P99 doi:10.1186/cc1804 |
||||||